Lina Benajiba

<i>TARDBP</i> mutations in motoneuron disease with frontotemporal lobar degeneration

Lina Benajiba, Isabelle Le Ber, Agnès Camuzat et al. · Annals of Neurology · 2009 · 301 citations

Corticobasal Degeneration, Genetics, Tardbp Mutations +18

The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia

Nina Fenouille, Christopher F. Bassil, Issam Ben‐Sahra et al. · Nature Medicine · 2017 · 118 citations · Full text

Hematological Malignancy, Signal Transduction, Biochemistry +10

Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial

Antonio M. Risitano, Alexander Röth, Juliette Soret et al. · The Lancet Haematology · 2021 · 100 citations

Thrombosis, Hematology, Pharmacology +7

Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia

Florence F. Wagner, Lina Benajiba, Arthur J. Campbell et al. · Science Translational Medicine · 2018 · 92 citations · Full text

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 80 citations · Full text